Mars B van 't Veer

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

E. Vellenga, W. van Putten, J. Zijlstra, 2006, Blood.